Actovegin vs ARA-290
Overview
Actovegin and ARA-290 are both pain management peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Actovegin and ARA-290 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Actovegin | ARA-290 | |
|---|---|---|
| Category | Pain Management | Pain Management |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 5-10 ml | 2-4 mg |
| Frequency | multiple weekly | daily for cycles |
| Reported benefits | Circulation-related pain relief, tissue oxygenation, healing support | Neuropathic pain reduction, nerve protection, diabetic neuropathy support |
| Reported side effects | Rare allergic reactions | Generally well-tolerated |
Key differences
Primary use. Actovegin is categorised under Pain Management, while ARA-290 falls under Pain Management. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Actovegin: not FDA-approved; treated as a research compound. ARA-290: not FDA-approved; treated as a research compound.
Dosing. Actovegin is typically dosed at 5-10 ml (multiple weekly). ARA-290 is typically dosed at 2-4 mg (daily for cycles).
Can you stack them?
Some protocols combine peptides, but stacking Actovegin and ARA-290 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Actovegin and ARA-290?
- Actovegin and ARA-290 are both pain management peptides, but they differ in mechanism, dosing, and regulatory status. Actovegin is not FDA-approved; generally classified as a research compound, whereas ARA-290 is not FDA-approved; generally classified as a research compound.
- What is Actovegin used for?
- Hypoxic pain and healing.
- What is ARA-290 used for?
- Neuropathic pain specialist.
- Can you take Actovegin and ARA-290 together?
- Some users combine peptides within a single protocol, but stacking Actovegin and ARA-290 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Actovegin or ARA-290 FDA-approved?
- Actovegin is not FDA-approved; generally classified as a research compound. ARA-290 is not FDA-approved; generally classified as a research compound.